{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:40:44Z","timestamp":1765294844679},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T00:00:00Z","timestamp":1487289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4,6]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by extensive immune response, including over-activation of T and B cell development of pathogenic autoantibodies, organ damage induced by the formation and deposition of immune complex and the abnormal elevation of type I interferon. Semaphorin5A (Sema5A) is involved essentially in immune cell regulation and is also implicated in the pathogenesis of autoimmune disorders. We aimed to evaluate the role of Sema5A in patients with SLE. Serum levels of Sema5A were tested by enzyme-linked immunosorbent assay (ELISA) in 152 SLE patients and 48 healthy controls. The message ribonucleic acid (mRNA) expression levels of Sema5A and ADAM metallopeptidase domain 17 (ADAM17) in the peripheral blood mononuclear cells (PBMC) from 43 patients with SLE and 19 healthy controls were detected by the real-time\u2013quantitative polymerase chain reaction (qPCR). Serum Sema5A levels were increased significantly in SLE patients compared with healthy controls (P\u2009&amp;lt;\u20090\u00b7001). Elevated levels of Sema5A were correlated positively with 24-h proteinuria excretion (r\u2009=\u20090\u00b7558, P\u2009&amp;lt;\u20090\u00b70001), SLE disease activity index (SLEDAI) (r\u2009=\u20090\u00b7278, P\u2009=\u20090\u00b70006) and C-reactive protein (CRP) (r\u2009=\u20090\u00b7266, P\u2009=\u20090\u00b7002), but negatively with planet (PLT) (r = \u20130\u00b7294, P\u2009=\u20090\u00b70003) and complement 3 (C3) (r = \u20130\u00b7287, P\u2009=\u20090\u00b70004) in SLE patients. Patients with elevated Sema5A levels showed higher incidence of rash, serositis and nephritis (P\u2009&amp;lt;\u20090\u00b705 or P\u2009&amp;lt;\u20090\u00b7001). Patients with decreased PLT, C3 or positive for proteinuria also showed elevated Sema5A (P\u2009&amp;lt;\u20090\u00b7001 or P\u2009&amp;lt;\u20090\u00b705). The mRNA ADAM17 was increased in SLE patients and correlated positively with serum Sema5A levels. Our data demonstrated that elevated serum Sema5A in SLE patients correlated with disease activity and are involved in kidney and blood system damage; ADAM17 might be involved in the release of secreted Sema5A.<\/jats:p>","DOI":"10.1111\/cei.12924","type":"journal-article","created":{"date-parts":[[2017,1,7]],"date-time":"2017-01-07T08:52:44Z","timestamp":1483779164000},"page":"234-242","source":"Crossref","is-referenced-by-count":21,"title":["Elevated semaphorin5A in systemic lupus erythematosus is in association with disease activity and lupus nephritis"],"prefix":"10.1093","volume":"188","author":[{"given":"Y","family":"Du","sequence":"first","affiliation":[{"name":"Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China"},{"name":"Department of Clinic Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"Xv","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Changzhou Tumor Hospital, Soochow University, Changzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,2,17]]},"reference":[{"key":"2021120808030335700_cei12924-bib-0001","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/1759720X13485503","article-title":"Biomarkers in systemic lupus erythematosus: challenges and prospects for the future","volume":"5","author":"Liu","year":"2013","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"2021120808030335700_cei12924-bib-0002","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nri976","article-title":"The autoantibody repertoire: searching for order","volume":"3","author":"Plotz","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"2021120808030335700_cei12924-bib-0003","first-page":"195","article-title":"Massive uncomplicated vascular immune complex deposits in the kidney of a patient with systemic lupus erythematosus","volume":"48","author":"Takazoe","year":"1997","journal-title":"Clin Nephrol"},{"key":"2021120808030335700_cei12924-bib-0004","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1177\/0961203311429116","article-title":"Immune function and brain abnormalities in patients with systemic lupus erythematosus without overt neuropsychiatric manifestations","volume":"21","author":"Kozora","year":"2012","journal-title":"Lupus"},{"key":"2021120808030335700_cei12924-bib-0005","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1126\/science.1125893","article-title":"Regulation of B cell tolerance by the lupus susceptibility gene Ly108","volume":"312","author":"Kumar","year":"2006","journal-title":"Science"},{"key":"2021120808030335700_cei12924-bib-0006","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJMe0800096","article-title":"Collaboration, genetic associations, and lupus erythematosus","volume":"358","author":"Crow","year":"2008","journal-title":"N Engl J Med"},{"key":"2021120808030335700_cei12924-bib-0007","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0962-8924(96)81033-6","article-title":"Semaphorins: mediators of repulsive growth cone guidance","volume":"6","author":"Kolodkin","year":"1996","journal-title":"Trends Cell Biol"},{"key":"2021120808030335700_cei12924-bib-0008","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/cmi.2009.111","article-title":"Regulation of immune cell responses by semaphorins and their receptors","volume":"7","author":"Takamatsu","year":"2010","journal-title":"Cell Mol Immunol"},{"key":"2021120808030335700_cei12924-bib-0009","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1182\/blood.V97.11.3498","article-title":"Functional soluble CD100\/Sema4D released from activated lymphocytes: possible role in normal and pathologic immune responses","volume":"97","author":"Wang","year":"2001","journal-title":"Blood"},{"key":"2021120808030335700_cei12924-bib-0010","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3346\/jkms.2006.21.3.478","article-title":"Disease-specific proteins from rheumatoid arthritis patients","volume":"21","author":"Kim","year":"2006","journal-title":"J Korean Med Sci"},{"key":"2021120808030335700_cei12924-bib-0011","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1016\/j.febslet.2011.03.033","article-title":"The role of immune semaphorins in multiple sclerosis","volume":"585","author":"Okuno","year":"2011","journal-title":"FEBS Lett"},{"key":"2021120808030335700_cei12924-bib-0012","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0925-4773(96)00525-4","article-title":"A novel class of murine semaphorins with homology to thrombospondin is differentially expressed during early embryogenesis","volume":"57","author":"Adams","year":"1996","journal-title":"Mech Dev"},{"key":"2021120808030335700_cei12924-bib-0013","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.neuron.2011.06.009","article-title":"Class 5 transmembrane semaphorins control selective mammalian retinal lamination and function","volume":"71","author":"Matsuoka","year":"2011","journal-title":"Neuron"},{"key":"2021120808030335700_cei12924-bib-0014","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/sj.embor.7400189","article-title":"Plexin-B3 is a functional receptor for semaphorin 5A","volume":"5","author":"Artigiani","year":"2004","journal-title":"EMBO Rep"},{"key":"2021120808030335700_cei12924-bib-0015","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/bjc.2012.298","article-title":"Secreted semaphorin 5A suppressed pancreatic tumour burden but increased metastasis and endothelial cell proliferation","volume":"107","author":"Sadanandam","year":"2012","journal-title":"Br J Cancer"},{"key":"2021120808030335700_cei12924-bib-0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mvr.2009.10.005","article-title":"Semaphorin 5A promotes angiogenesis by increasing endothelial cell proliferation, migration, and decreasing apoptosis","volume":"79","author":"Sadanandam","year":"2010","journal-title":"Microvasc Res"},{"key":"2021120808030335700_cei12924-bib-0017","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/ijc.25166","article-title":"High gene expression of semaphorin 5A in pancreatic cancer is associated with tumor growth, invasion and metastasis","volume":"127","author":"Sadanandam","year":"2010","journal-title":"Int J Cancer"},{"key":"2021120808030335700_cei12924-bib-0018","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1089\/omi.2006.0004","article-title":"Identification of functional cell adhesion molecules with a potential role in metastasis by a combination of in vivo phage display and in silico analysis","volume":"11","author":"Sadanandam","year":"2007","journal-title":"Omics"},{"key":"2021120808030335700_cei12924-bib-0019","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.3748\/wjg.15.2800","article-title":"Expression of semaphorin 5A and its receptor plexin B3 contributes to invasion and metastasis of gastric carcinoma","volume":"15","author":"Pan","year":"2009","journal-title":"World J Gastroenterol"},{"key":"2021120808030335700_cei12924-bib-0020","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.1073\/pnas.0601015103","article-title":"Evidence that bovine forebrain embryonic zinc finger-like gene influences immune response associated with mastitis resistance","volume":"103","author":"Sugimoto","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021120808030335700_cei12924-bib-0021","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/art.38425","article-title":"Secreted semaphorin 5A activates immune effector cells and is a biomarker for rheumatoid arthritis","volume":"66","author":"Gras","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2021120808030335700_cei12924-bib-0022","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.thromres.2015.07.032","article-title":"Elevated Semaphorin 5A correlated with Th1 polarization in patients with chronic immune thrombocytopenia","volume":"136","author":"Lyu","year":"2015","journal-title":"Thromb Res"},{"key":"2021120808030335700_cei12924-bib-0023","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2021120808030335700_cei12924-bib-0024","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","article-title":"Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE","volume":"35","author":"Bombardier","year":"1992","journal-title":"Arthritis Rheum"},{"key":"2021120808030335700_cei12924-bib-0025","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/gb-2006-7-3-211","article-title":"The semaphorins","volume":"7","author":"Yazdani","year":"2006","journal-title":"Genome Biol"},{"key":"2021120808030335700_cei12924-bib-0026","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0092-8674(00)80766-7","article-title":"Semaphorin Nomenclature Committee. Unified nomenclature for the semaphorins\/collapsins","volume":"97","year":"1999","journal-title":"Cell"},{"key":"2021120808030335700_cei12924-bib-0027","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00018-005-5018-2","article-title":"Plexins: axon guidance and signal transduction","volume":"62","author":"Negishi","year":"2005","journal-title":"Cell Mol Life Sci CMLS"},{"key":"2021120808030335700_cei12924-bib-0028","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1002\/dvdy.21556","article-title":"Expression of the semaphorins Sema 3D and Sema 3F in the developing parathyroid and thymus","volume":"237","author":"Takahashi","year":"2008","journal-title":"Dev Dyn"},{"key":"2021120808030335700_cei12924-bib-0029","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.autrev.2010.07.014","article-title":"Neuropilins and semaphorins \u2013 from angiogenesis to autoimmunity","volume":"9","author":"Vadasz","year":"2010","journal-title":"Autoimmun Rev"},{"key":"2021120808030335700_cei12924-bib-0030","doi-asserted-by":"crossref","first-page":"R146","DOI":"10.1186\/ar3881","article-title":"Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus","volume":"14","author":"Vadasz","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"2021120808030335700_cei12924-bib-0031","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1177\/0961203312456753","article-title":"Semaphorin 3A \u2013 a marker for disease activity and a potential putative disease-modifying treatment in systemic lupus erythematosus","volume":"21","author":"Vadasz","year":"2012","journal-title":"Lupus"},{"key":"2021120808030335700_cei12924-bib-0032","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.coi.2012.10.004","article-title":"The pathogenesis of systemic lupus erythematosus \u2013 an update","volume":"24","author":"Choi","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"2021120808030335700_cei12924-bib-0033","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jaut.2007.02.005","article-title":"Clearance deficiency and systemic lupus erythematosus (SLE)","volume":"28","author":"Gaipl","year":"2007","journal-title":"J Autoimmun"},{"key":"2021120808030335700_cei12924-bib-0034","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nrrheum.2010.46","article-title":"The role of defective clearance of apoptotic cells in systemic autoimmunity","volume":"6","author":"Munoz","year":"2010","journal-title":"Nat Rev Rheumatol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.12924","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/188\/2\/234\/41642899\/cei12924.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/188\/2\/234\/41642899\/cei12924.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T16:27:39Z","timestamp":1641054459000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/188\/2\/234\/6411982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,17]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2,17]]},"published-print":{"date-parts":[[2017,4,6]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.12924","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"type":"electronic","value":"1365-2249"},{"type":"print","value":"0009-9104"}],"subject":[],"published-other":{"date-parts":[[2017,5]]},"published":{"date-parts":[[2017,2,17]]}}}